Cohen & Steers, Inc. (CNS) Stock Price & Analysis
Cohen & Steers, Inc. (CNS) closed at USD 72.07 on Thursday, October 22, 2026, up 2.58% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 70.26; the Oct 22, 2026 session ranged USD 69.47–72.11 on volume of 229,202 shares. Market capitalization is $3.71B, with a 52-week range of USD 58.39–86.56 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CNS.md
Key facts (CNS)
- Last four reported quarters (through Jun 30, 2026): revenue $584M, net income $168M (28.8% margin) (SEC filings).
- Valuation: P/E 22.0x (avg 27.1x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold CNS (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Hold (mean 3.33 on a 1–5 scale) (3 analysts), mean target USD 71.67 (range 53–82).
- Total return with dividends: 1Y +5.7% vs S&P 500 +14.9%; 5Y -7.4% vs S&P 500 +80.3%.
- Next earnings: 2026-10-15, EPS estimate USD 0.81, revenue estimate $155M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CNS)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $584M | $567M | $490M | $517M | $556M | $584M |
| Operating income | $260M | $216M | $164M | $173M | $178M | $192M |
| Net income | $211M | $171M | $129M | $151M | $153M | $168M |
| EPS (diluted) | $4.31 | $3.47 | $2.60 | $2.97 | $2.97 | — |
| Free cash flow | $240M | $57.5M | $115M | $85.0M | -$126M | — |
| Operating margin | 44.6% | 38.1% | 33.6% | 33.4% | 32.0% | 32.9% |
| Net margin | 36.2% | 30.2% | 26.4% | 29.2% | 27.6% | 28.8% |
| Revenue growth | +36.6% | -2.9% | -13.6% | +5.7% | +7.5% | — |
| Cash + short-term investments | $184M | $247M | $187M | $183M | $145M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CNS)
P/E 22.0x · P/S 6.3x · P/B 6.3x · Earnings yield 4.54% · Dividend yield (paid, TTM) 3.58% · Buyback yield (TTM) 0.52%
P/E at fiscal year-ends: Dec 2025 21.1x, Dec 2024 31.1x, Dec 2023 29.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (CNS)
1 of 80 tracked investors hold CNS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | <0.01% | $21K | Added +345.9% |
Analysts (CNS)
Consensus Hold (mean 3.33 on a 1–5 scale), 3 analysts; mean target USD 71.67 (low 53, high 82).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-09 | Evercore ISI Group | Target raised | Outperform | $88 → $89 |
| 2026-08-10 | Evercore ISI Group | Target raised | Outperform | $84 → $88 |
| 2026-07-10 | Evercore ISI Group | Target raised | Outperform | $82 → $84 |
Total return (dividends reinvested) (CNS)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +5.7% | -7.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +5.8% | -1.5% |
| Volatility (annualized) | 27.2% | 30.4% |
| Max drawdown | -22.5% (Aug 2026→Oct 2026) | -46.0% (Nov 2021→Oct 2023) |
CNS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.81 | $0.95 | -15.2% | $154.8M | 1 |
| Next quarter (ends Mar 2027) | $0.80 | $0.96 | -16.7% | $153.0M | 1 |
| Current fiscal year (ends Dec 2026) | $3.52 | $3.52 | +0.0% | $612.5M | 2 |
| Next fiscal year (ends Dec 2027) | $3.74 | $3.87 | -3.5% | $646.4M | 3 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 72.07 |
|---|---|
| Change | ▲ 2.58% (up) |
| Previous Close | USD 70.26 |
| Open | USD 69.9 |
| Day Range | USD 69.47 – 72.11 |
| 52-Week Range | USD 58.39 – 86.56 |
| Volume | 229,202 shares |
| Market Cap | $3.71B |
| Exchange | NYQ |
Technical Analysis (CNS)
Nexqual's technical model rates CNS "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.97 (neutral) |
| vs SMA50 | Below (USD 75.65) |
| MACD | -1.44 (negative) |
Analyst Ratings (CNS)
Wall Street analysts rate CNS "Hold" based on 3 analysts, with a mean price target of USD 71.67 (range USD 53–82), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 71.67 |
| High Target | USD 82 |
| Low Target | USD 53 |
| Buy / Hold / Sell | 1 / 1 / 1 |
Earnings (CNS)
| Next Earnings Date | 2026-10-15 |
|---|---|
| EPS Estimate | USD 0.81 |
| Revenue Estimate | $154.82M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.89 vs est 0.91 ▼ miss |
| 2026-06-30 | USD 0.85 vs est 0.86 ▼ miss |
| 2026-03-31 | USD 0.79 vs est 0.82 ▼ miss |
| 2025-12-31 | USD 0.81 vs est 0.81 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (CNS)
| Total Revenue | $599.60M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +11.10% |
| Gross Margin | +46.57% |
| Operating Margin | +32.44% |
| Profit Margin | +28.16% |
| Debt / Equity | 0.19 |
| Total Cash | $282.61M |
| Total Debt | $134.39M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | -$126.42M (-22.7% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (CNS)
Nexqual rates Cohen & Steers, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 47%, operating 32% (last 12 months) |
| Balance Sheet | Strong — $283M cash vs $134M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$126M (FY ended Dec 2025, 10-K), burning cash |
| Efficiency | Mixed — No data |
Ownership (CNS)
| Insider Ownership | +45.83% |
|---|---|
| Institutional Ownership | +58.26% |
| Shares Outstanding | 51.42M |
| Float | 27.69M |
| Short % of Float | +5.95% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (CNS)
Cohen & Steers, Inc. is led by Joseph M. Harvey, CEO & Director, per Nexqual as of October 23, 2026 at 09:25 UTC.
| CEO & Director | Joseph M. Harvey |
|---|---|
| Founder & Executive Chairman | Robert Hamilton Steers |
| Co-Founder & Chairman | Martin Cohen |
| President & Chief Investment Officer | Jon Cheigh |
| Executive VP & COO | Adam Derechin C.F.A. |
Major Backers & Investors (CNS)
Notable institutional backers of Cohen & Steers, Inc. include Wasatch Advisors LP, Charles Schwab Investment Management, Inc., Victory Capital Management Inc., according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wasatch Advisors LP | 2.16% |
| Charles Schwab Investment Management, Inc. | 2.07% |
| Victory Capital Management Inc. | 1.87% |
| Goldman Sachs | 1.8% |
| Charles Schwab | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.77% |
| Vanguard Group | 5.76% |
| Dimensional Fund Advisors | 2.33% |
| State Street | 2.32% |
| Geode Capital | 1.72% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BXSL | Blackstone Secured Lending Fund | USD 23.91 | ▲ 2.31% |
| VCTR | Victory Capital Holdings, Inc. | USD 107.39 | ▼ 0.2% |
| PDI | PIMCO Dynamic Income Fund | USD 14.3 | ▲ 1.2% |
| AMG | Affiliated Managers Group, Inc. | USD 395.53 | ▲ 0.48% |
| SEIC | SEI Investments Company | USD 104.5 | ▼ 3.62% |
| IVZ | Invesco Ltd | USD 28.79 | ▼ 1.57% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt